Carlos Alfaras's Email & Phone Number

💼 Past Experience

Prior to his current role at GENSCO Pharma in Miami, Carlos Alfaras served as the CEO of Gensco Pharma. responsible for the day-to-day operations of the company. during his time at Gensco Pharma, Carlos led the development of two groundbreaking product lines - NFLx and GENUIRX - which have received strong reviews from patients and doctors.As CEO of Gensco Pharma, Carlos spearheaded an ambitious expansion plan, which saw the company operations expand from multiple units in Spain to operations throughout Latin America and the Caribbean. In total, Gensco Pharma has now operations in 27 countries.Under Carlos Alfaras’ leadership, Gensco Pharma grew from a young start-up to become a successful global player in the biotechnology industry. In laying the foundation for Gensco Pharma to reach its present day stature, he drove innovation andqq veteran employeesBelieved that Ideation and Execution are the two central tenets of Catalan Business.The quality of Gensco Pharma’s products has been initiatives which has seen the company appreciated by patients, clinicians and pharmaceutical industry. With the acquisition of NFLx by AbbVie in late 2017, Gensco Pharma became the first company in the industry to receive FDA approval for a product related to the American Football League.Prior to joining Gensco Pharma, Carlos Alfaras served as a Research Scientist at Inovio Pharmaceuticals. during his time at Inovio, Carlos furthered the development of two products - ipilimumab and eksititide - which have been successful in both trials and commercialization. In addition, Carlos played a key role in Inovio Pharmaceuticals’ achievement of regulatory approvals for two novel products - ulnar nerve sheathiram and infliximab - which have helped the company to enter new markets and generate unprecedented sales.Important milestones which Carlos Alfaras acknowledged during his time at Inovio Pharmaceuticals include the successful completion of the pivotal Phase III study of ipilimumab, and ushering in a new era for Inovio Pharmaceuticals with the launch of eksititide.Following his time with Inovio Pharmaceuticals, Carlos Alfaras served as a Consultant in the Biotechnology Sector at Novartis AG. during his time at Novartis AG, Carlos led the company’s transition from an early stage company to a major global player in biotechnology. He also played a critical role in the development of several world-class biotherapy products, including erlotinib and semetinib.Carlos Alfaras’s priorities when it comes to work are both the acquisition of new products and the retention of veteran employees. He is adamant about the importance of Ideation and Execution in Catalan Business. He believes that these two pillars are the foundation for any successful company, and that they are essential for any company that wants to grow and succeed.Under Carlos Alfaras, Gensco Pharma has become a major player in the biotechnology industry, winning regulatory approvals for new products and expanding operations around the globe.

🎓 Education

Carlos Alfaras's education has biomechanical engineering focus. He studied at the University of Miami from 1986 to 1989 and is a graduate of the University of Miami with a degree in biomechanical engineering. Alfaras has a past experience working with robots, which has helped him prepare for his current job as a Robotics Engineer for Sheridan Controls.

💡 Technical & Interpersonal Skills

Carlos Alfaras has over 10 years of experience as a CEO and Chair of a business unit at Gensco Pharma. In his role as CEO, he has led the company toisitions, successfully developed and launches new products, and successes in its strategic alliances. He has also been responsible for leading the company's efforts to expand its reach into new markets and jurisdictions. Additionally, Carlos is a natural leader and has a strong understanding of the business environment and its fluidity. He is also highly responsive to feedback and innovation, and is able to take————————————————————— ownership and execution of projects to ensure success.